AI assistant
Sending…
ArcticZymes Technologies — Director's Dealing 2010
Feb 23, 2010
3538_dirs_2010-02-23_7a2dc111-2df1-4a07-b45a-6fa9047df485.html
Director's Dealing
Open in viewerOpens in your device viewer
Notification of trade primary insider
Scientific Advisor of Biotec Pharmacon, Dr. Rolf
Seljelid, has today purchased 25,000 shares in the
Company at an average price of NOK 4.00 per share.
Dr. Seljelid holds 75,000 shares after this
transaction.
More from ArcticZymes Technologies
Interim / Quarterly Report
2026
May 7
Call Transcript
2026
May 7
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
AGM Information
2026
May 6
AGM Information
2026
May 6
Investor Presentation
2026
May 4
Environmental & Social Information
2026
Apr 30
Annual Report
2026
Apr 30
Annual Report
2026
Apr 30